• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
JAT 3.45% 2.8¢

JATCORP LIMITED - Corporate Spotlight

Origination, development and manufacture of a range of consumer products, associated... Origination, development and manufacture of a range of consumer products, associated brand development, marketing and promotion and the sale of client and in-house products, primarily in Australia and China via a multichannel strategy including traditional retail, and e-commerce platforms.More

Corporate Spotlight

Origination, development and manufacture of a range of consumer products, associated brand development, marketing and promotion and the sale of client and in-house products, primarily in Australia and China via a multichannel strategy including traditional retail, and e-commerce platforms.
View the full Corporate Spotlight arrow Created with Sketch.

JAT subsidiary enters $32M contract

JAT GRANTED CHINESE APPROVAL COSMETICS

arrow-down-2 Created with Sketch.


Jatcorp (ASX:JAT) granted Chinese approval for first cosmetic product

Consumer Discretionary

ASX:JAT   
Jatcorp (ASX:JAT) - Managing Director, Wilton Yao - The Market Herald
Managing Director, Wilton Yao

  • The Chinese Food and Drug Administration has approved Jatcorp's (JAT) first cosmetic product under the "Poupin" skincare brand
  • JAT's joint venture company, JWR International, is developing this range to be sold in local department and cosmetic stores across China
  • Additionally, Hainan Xinwang Investments has been appointed to distribute JAT's in-house brands in the Hainan Island Tax Free Zone for 12 months
  • Hainan Xinwang operates online and offline duty-free stores, which have the potential to be significant sales drives for Jatcorp's products

Jatcorp (JAT) has announced the Chinese Food and Drug Administration has approved its first cosmetic product under the "Poupin" skincare brand.


The brand is being developed by Jatcorp's Hong Kong-based joint venture (JV) company, JWR International. 


The first product that has been given the green tick is the Poupin Silky Brighten Revitalising Serum which can now be sold in China through offline channels such as local department stores and specialty cosmetic stores.


Jatcorp and its JV partner will arrange for the Poupin range to be promoted and sold through online platforms such as the most popular social media influencer sales channels.


In addition, the company appointed Hainan Xinwang Investments to distribute its in-house brands in the Hainan Island Tax Free Zone for 12 months. 


Hainan Xinwang operates the Easy Joy International stores on the island which has duty-free stores both online and offline. These have the potential to be significant sales drivers for Jatcorp's products.


Lastly, JAT's subsidiary, Sunnya, has successfully opened the Singapore market to its Neurio range of milk powder products. These products can now be sold in local Singaporean pharmacies as well as online in Indonesia, Malaysia and the Philippines. 



Read the full article on The Market Herald here.

JATCORP'S SUBSIDIARY $32M CONTRACT

arrow-down-2 Created with Sketch.


Jatcorp’s (ASX:JAT) subsidiary enters $32M contract agreement

Consumer Discretionary

ASX:JAT    
Jatenergy signs two new distribution agreements at CIIE


  • Jatcorp's (JAT) subsidiary Sunnya has entered a contract agreement to supply up to $32 million worth of their products to a major distributor
  • Shandong Puxuan Trading Co supplies mother and baby products across 20,000 Kigo Baby stores in the Chinese region
  • Sunnya has agreed to supply its full range of Neurio products to Shandong over the next 12 months, after previously working with the company for two years
  • In return, the distributor will pay a $100,000 initial security bond, while Jatcorp's subsidiary stands to make up to $32 million in revenue

Jatcorp's (JAT) subsidiary Sunnya has entered a contract agreement to supply up to $32 million worth of their products to a major distributor in China.


The company in question is Shandong Puxuan Trading Co, which supplies mother and baby products across 20,000 Kigo Baby stores in the region.


Sunnya and Shandong have previously worked together over the last two year, with the distributor purchasing around $14 million worth of products across 2020.


Under this new 12-month agreement, Sunnya has agreed to supply its full range of Neurio products to Shandong over the next 12 months, with the possibility of another one-year extension.


The Chinese distributor must pay a $100,000 security bond and a deposit of 20 per cent of the order's total before handing over the full amount once the product's clear customs.


In return, the Jatcorp subsidiary estimates it could walk away with up to $32 million worth of revenue from the business.

JAT advises that the first security payment by Shandong has been received, with the new contract officially beginning on February 3.


The company also revealed its planned expansion of the ANMA manufacturing facility in Melbourne is progressing well and should be completed this month.


Shares in Jatcorp were placed into a trading halt ahead of Thursday's announcement, with the stock now resuming trade.


Read the full article on The Market Herald here.

JAT TO RAISE $2.8M FOR ANMA EXPANSION

arrow-down-2 Created with Sketch.


Jatcorp (ASX:JAT) to raise $2.8M for ANMA expansion

Consumer

ASX:JAT   
Jatcorp (ASX:JAT) - Managing Director, Wilton Yao - The Market Herald

Managing Director, Wilton Yao
Source: Jatcorp

  • China-Australia trade company Jatcorp (JAT) has received applications to undertake a $2.8 million placement
  • More than 148.8 million fully-paid ordinary shares will be issued to sophisticated and professional investors at 1.9 cents 
  • Subject to shareholder approval, participants will receive one free-attaching option for every two shares subscribed for, exercisable at 0.6 cents on or before January 29, 2023 
  • Once received, Jatcorp will use the funds to expand its ANMA manufacturing facility, develop new products and provide working capital
  • After emerging from a trading halt, shares in Jatcorp are steady on the market and are trading at 2.3 cents

China-Australia trade company Jatcorp (JAT) has received applications to undertake a $2.8 million placement. 


The company entered a trading halt on Wednesday but did not disclose how much it would be raising or what the funds will be used for. 


All up, 148,817,781 fully-paid ordinary shares will be issued to sophisticated and professional investors at 1.9 cents. 


Furthermore, subject to shareholder approval, investors will receive one free-attaching option for every two shares subscribed for, exercisable at 0.6 cents on or before January 29, 2023. 


Also subject to shareholder approval, 10 million shares will be issued to Chairman Brett Crowley to raise an additional $200,000. 


Once received, Jatcorp will use the funds to expand its ANMA manufacturing facility, develop new products and provide working capital. 


The ANMA facility, which is located in Melbourne, produces Jatcorp's milk formula products. 


Read the full article on The Market Herald here.

JAT ENTERS TRADING HALT AHEAD OF RAISE

arrow-down-2 Created with Sketch.


Jatcorp (ASX:JAT) enters trading halt ahead of fundraise

The Market Herald Deal Room

ASX:JAT   
 
JAT seeks new funding as business sales exceed expectations

  • China-Australia trade specialist Jatcorp (JAT) has placed its securities in a trading halt as it gears up to raise funds
  • The company will remain in a halt until Friday, January 22, unless it can announce the details of the capital raise early
  • More recently, Jatcorp has been focussed on opening its JAT Maternity & Infant Boutique in Shanghai
  • The retail store is on track to open in late February or early March, after being delayed by COVID-19 related lockdowns in the city
  • Additionally, the company recently revealed work had begun on extending its ANMA manufacturing facility in Melbourne

China-Australia trade specialist Jatcorp (JAT) has placed its securities in a trading halt as it gears up for a fundraise.


The company has announced its shares will remain in a halt until Friday, January 22, unless it announces the details of the capital raise early.


The fundraise comes after Jatcorp revealed earlier this month that it had been focussed on progressing its JAT Maternity & Infant Boutique in Shanghai.


The retail store is on track to open in late February or early March after being previously delayed by COVID-19 related lockdowns in the city.


Once the boutique opens, JAT anticipates it will turn over between $500,000 and $800,000 in the first year of trade.


In addition to the store opening, Jatcorp also revealed work had begun on extending its ANMA manufacturing facility in Melbourne.


Works at the facility have already commenced and the company expects the expansion to be completed by the end of next month.


Before today's trading halt, shares in JAT were trading at 2.3 cents each on Tuesday, January 19.


Read the full article on The Market Herald here.

JATCORP STARTS FIT-OUT ON RETAIL STORE

arrow-down-2 Created with Sketch.



Jatcorp (ASX:JAT) starts fit-out on first retail store

Consumer Discretionary

ASX:JAT  

  • Jatcorp (JAT) has begun fit-out work on its first retail store in China, JAT Maternity & Infant Boutique
  • The store was originally expected to open in March 2020, however, due to COVID-19 lockdowns and restrictions, the opening was delayed
  • The directors expect the turnover for the store will be between $500,000 and $800,000 in the first year of trading
  • The store is set to establish JAT’s image in the Chinese market, promote the company and expand the influence of the company’s products in China

Jatcorp (JAT) has begun fit-out work on its first retail store in China, JAT Maternity & Infant Boutique.

The first store, to be opened in Shanghai, was previously expected to open in March 2020, however, due to COVID-19 lockdowns and restrictions, the opening was delayed.

The store is set to establish JAT’s image in the Chinese market, promote the company and expand the influence of the company’s products in China.

The fit-out works for the new store have now begun, with the company aiming to open the store for trading in late February or early March 2021.

JAT Maternity & Infant Boutique covers square metres and is located next to the Sinopharm pharmacy, a move expected to drive significant consumer traffic to the JAT Store.

The store will sell a full range of in-house brands including Neurio, Moroka, Ione Milk and Abbeyard, as well as other popular baby products produced by Australia and China.

The directors expect the turnover for the store will be between $500,000 and $800,000 in the first year of trading.

The establishment of the Shanghai store will also assist in driving consumers to JAT’s online China sales platform, which will be established by JAT’s newly established subsidiary, Hangzhou FAT Food Group.


If the Shanghai store is successful, JAT intends to open further stores in Shanghai and other cities in China.

Read the full article on The Market Herald here. 

JATCORP EXPANDS INTO SOUTH KOREA

arrow-down-2 Created with Sketch.

Jatcorp (ASX:JAT) expands into South Korean market

Consumer

ASX:JAT   
Jatcorp (ASX:JAT) - Managing Director, Wilton Yao - The Market Herald

Managing Director, Wilton Yao
Source: Jatcorp


  • Jatcorp (JAT) has signed a sole agency agreement with Max Core Med Co to sell and distribute its milk powder brand in South Korea
  • Under the two year agreement, Jatcorp will receive $2.4 million in minimum orders in year one and $4.8 million in year two
  • It comes after the consumer stock inked a 10-year sales agreement with Nightingale PS just two days earlier
  • Jatcorp's subsidiary, ANMA, had also been approved by South Korean regulatory authority KFDA to sell its products in Korea
  • Jatcorp is up an even four per cent on the market and shares are trading at 2.6 cents


Jatcorp (JAT) has signed a sole agency agreement with Max Core Med Co to sell and distribute its milk powder brand in South Korea. 

Under the two-year agreement, Jatcorp will receive $2.4 million in minimum orders in year one and $4.8 million in year two. 


If these orders are not met, JAT has the right to terminate the agreement. It can also be terminated if any breach happens and is not fixed within 30 days. 


It comes after the consumer stock inked a 10-year sales agreement with Nightingale PS just two days earlier


This agreement will see Nightingale sell Jatcorp's existing and future products to its own customers, which include pharmacies and supermarkets across Australia and the U.K. 


Jatcorp also announced that its subsidiary, ANMA, had been approved by the South Korean regulatory authority, KFDA, to sell its products in Korea.


"We are delighted to have secured entry into the South Korean market in partnership with Max Core. We are confident based on their track record that the team at Max Core will achieve the minimum sales targets and more," CEO Wilton Yao said. 


"JAT is now seeing the benefit of the expenditure incurred in expanding our ANMA manufacturing facility. The greater capacity will allow JAT to increase its product range and volume to be able to enter the Korean and other world markets," he added.



Read the full article on The Market Herald here.

JAT SIGNS 10-YEAR DISTRIBUTION AGREEMENT

arrow-down-2 Created with Sketch.

Jatcorp (ASX:JAT) signs 10-year distribution agreement

Consumer

ASX:JAT   
Jatenergy (ASX:JAT) sees increased lactoferrin sales in China due to the coronavirus



  • Consumer goods developer and manufacturer Jatcorp (JAT) has announced it has entered into a 10-year sales agreement with Nightingale PS
  • The agreement will see Nightingale sell Jatcorp's existing and future products to its own customers, which include pharmacy and supermarket chains
  • Alongside the sale agreement, JAT also announced it had been approved by the South Korean regulatory authority to export its dairy products
  • The company has now signed an agreement with a Korean distributor for an initial order of its products for resale
  • Finally, Jatcorp also announced it has successfully developed its first A2 Ejiao Protein Powder, with plans to begin selling the product next year

Jatcorp (JAT) has released a wideranging business update, announcing a new sales agreement, product expansion and potential market gain.


Sales agreement

The biggest news from the consumer goods developer and manufacturer was that it has entered into a 10-year sales agreement with Nightingale PS.


Under the agreement, Nightingale will sell Jatcorp's existing and future products to its own customers, which include pharmacy and supermarket chains across Australia and the U.K.


In return, the business will receive a commission on revenues from sales of any and all of JAT's products.


Nightingale has stated it will first aim to sell Jatcorp's wares to Australian supermarket chains, followed by sales to pharmacies also within the country.


The company will then focus on selling JAT products to its U.K. customers and potentially other markets outside China.


New product & market

Alongside the sales agreement, Jatcorp also announced it has successfully developed its first A2 Ejiao Protein Powder.


Ejiao is essentially a hard gel which can be dissolved in hot water or alcohol to be used in food, drink or beauty product.


The substance is currently sold throughout south-east Asia as consumers believe its helps with blood circulation.


Jatcorp's version of the product is currently being manufactured in Melbourne, with the possibility it will be ready to be sold by early 2021.


Finally, the consumer stock also announced in today's update that it had been approved to sell its products in Korea.


The South Korean regulatory authority has given the green light to JAT's dairy based nutritional products — allowing them to be exported into the country.


Following the approval, Jatcorp has begun negotiating with different Korean companies to export in JAT’s Jinvigorate brand diabetics formula and other products.


Shares in Jatcorp are trading slightly down despite today's update, dropping 3.57 per cent in the red to trade at 2.7 cents each at 1:22 pm AEDT.



Read the full article on The Market Herald here.

ABOUT US

arrow-down-2 Created with Sketch.


DRAWING ON ITS EXTENSIVE BUSINESS NETWORK IN CHINA, JAT HAS POSITIONED ITSELF AS A MAJOR PLAYER IN THE FLOURISHING AUSTRALIAN CONSUMER GOODS EXPORT INDUSTRY.


In addition JAT markets energy related technologies including TTG Mineral Processing and Coalplus conversion.


Jat’s extensive network of Chinese business affiliations is a substantial source of opportunities, both for the company, and for Australian business partners.

(20min delay)
Last
2.8¢
Change
-0.001(3.45%)
Mkt cap ! $38.78M
Open High Low Value Volume
2.8¢ 2.8¢ 2.8¢ $5.108K 182.4K

Buyers (Bids)

No. Vol. Price($)
18 4089790 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 591183 5
View Market Depth
Last trade - 10.25am 21/04/2021 (20 minute delay) ?
(live)
Last
2.8¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
2.9¢ 2.9¢ 2.8¢ 1200305
Last updated 12.34pm 21/04/2021 (live) ?
JAT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.